# Silver Nitrate vs. Triamcinolone for Treatment of Hypergranulation Tissue

> **NCT06681194** · PHASE2,PHASE3 · NOT_YET_RECRUITING · sponsor: **Francesco Egro** · enrollment: 270 (estimated)

## Conditions studied

- Wound Healing
- Granulation Tissue

## Interventions

- **DRUG:** Silver Nitrate
- **DRUG:** triamcinolone
- **DRUG:** Silver nitrate + triamcinolone

## Key facts

- **NCT ID:** NCT06681194
- **Lead sponsor:** Francesco Egro
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-06-01
- **Primary completion:** 2028-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 270 (ESTIMATED)
- **Last updated:** 2025-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06681194

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06681194, "Silver Nitrate vs. Triamcinolone for Treatment of Hypergranulation Tissue". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT06681194. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*